OurCrowd will be focusing on early-stage investments in 2020 because this time, the company will try to look 10 years ahead, says Jerusalem-based equity crowdfunding company OurCrowd Ltd. CEO Jon Medved.
Read more here.
OurCrowd will be focusing on early-stage investments in 2020 because this time, the company will try to look 10 years ahead, says Jerusalem-based equity crowdfunding company OurCrowd Ltd. CEO Jon Medved.
Read more here.
![[CytoReason in Mobi Health News] Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
